Table of Contents
SECURITIES AND EXCHANGE COMMISSION
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the quarterly period ended July 31, 2003 | ||
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the transition period from to |
OMNIVISION TECHNOLOGIES, INC.
Delaware | 77-0401990 | |
(State or other jurisdiction | (I.R.S. Employer | |
of incorporation or organization) | Identification Number) |
1341 Orleans Drive, Sunnyvale, California 94089-1136
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (408) 542-3000
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yesx Noo
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yesx Noo
At September 10, 2003, 53,861,596 shares of common stock of the Registrant were outstanding.
EXPLANATORY NOTE
This amended Quarterly Report on Form 10-Q/A is being filed for the purpose of amending and restating Items 1, 2 and 4 of Part I and Item 6 of Part II of the Form 10-Q originally filed solely to the extent necessary (i) to reflect the restatement of our condensed consolidated financial statements as of and for the period ended January 31, 2004 as described in Note 1 to the condensed consolidated financial statements and to report in the equity section of the balance sheet the benefit from exercises of stock options, (ii) to make revisions to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as warranted by the restatement (which do not include “Factors Affecting Future Results”), (iii) to make revisions to Item 4 of Part I to reflect our evaluation of controls and procedures as of the date of filing of this amended Quarterly Report on Form 10-Q, (iv) to include the certifications required by the Sarbanes-Oxley Act of 2002 and (v) to update the exhibits in accordance with this amended Quarterly Report on Form 10-Q. We have made no further changes to the previously filed Form 10-Q. All information in this amended Quarterly Report on Form 10-Q is as of the date the Quarterly Report on Form 10-Q was originally filed and does not reflect any subsequent information or events other than those reflected in the restatement.
OMNIVISION TECHNOLOGIES, INC.
INDEX
Page | ||||||||
PART I. FINANCIAL INFORMATION | ||||||||
Item 1. | ||||||||
3 | ||||||||
4 | ||||||||
5 | ||||||||
6 | ||||||||
Item 2. | 16 | |||||||
Item 3. | 25 | |||||||
Item 4. | 25 | |||||||
PART II. OTHER INFORMATION | ||||||||
Item 1. | 28 | |||||||
Item 2. | 29 | |||||||
Item 5. | 29 | |||||||
Item 6. | 29 | |||||||
Signatures | 31 | |||||||
EXHIBIT 31.1 | ||||||||
EXHIBIT 31.2 | ||||||||
EXHIBIT 32 |
2
Table of Contents
PART I — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
OMNIVISION TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)
July 31, | April 30, | |||||||
2003 | 2003 | |||||||
(restated) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 164,898 | $ | 50,438 | ||||
Short-term investments | 15,997 | 10,224 | ||||||
Accounts receivable, net | 26,892 | 19,133 | ||||||
Inventories | 15,565 | 13,642 | ||||||
Refundable and deferred income taxes | 6,438 | 7,642 | ||||||
Prepaid expenses and other assets | 2,310 | 1,195 | ||||||
Total current assets | 232,100 | 102,274 | ||||||
Property, plant and equipment, net | 15,863 | 12,456 | ||||||
Long-term investments | 4,854 | 2,845 | ||||||
Other non-current assets | 387 | 378 | ||||||
Total assets | $ | 253,204 | $ | 117,953 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 19,731 | $ | 10,528 | ||||
Accrued expenses and other liabilities | 12,032 | 8,037 | ||||||
Deferred income on shipments to distributors | 2,219 | 2,845 | ||||||
Total current liabilities | 33,982 | 21,410 | ||||||
Commitments and contingencies (Note 7) | ||||||||
Stockholders’ equity: | ||||||||
Common stock, $0.001 par value; 100,000,000 shares authorized; 53,613,672 and 46,805,816 shares issued and outstanding | 54 | 47 | ||||||
Additional paid-in capital | 221,215 | 104,824 | ||||||
Deferred compensation related to stock options | (102 | ) | (159 | ) | ||||
Accumulated deficit | (1,945 | ) | (8,169 | ) | ||||
Total stockholders’ equity | 219,222 | 96,543 | ||||||
Total liabilities and stockholders’ equity | $ | 253,204 | $ | 117,953 | ||||
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
3
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED INCOME STATEMENTS
(unaudited)
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
(restated) | ||||||||
Revenues | $ | 46,839 | $ | 16,790 | ||||
Cost of revenues(1) | 29,460 | 10,274 | ||||||
Gross profit | 17,379 | 6,516 | ||||||
Operating expenses: | ||||||||
Research and development | 3,580 | 2,630 | ||||||
Selling, general and administrative | 4,490 | 2,080 | ||||||
Stock-based compensation charge(2) | 101 | 114 | ||||||
Total operating expenses | 8,171 | 4,824 | ||||||
Income from operations | 9,208 | 1,692 | ||||||
Interest income, net | 222 | 216 | ||||||
Income before income taxes | 9,430 | 1,908 | ||||||
Provision for income taxes | 3,206 | 286 | ||||||
Net income | $ | 6,224 | $ | 1,622 | ||||
Net income per share: | ||||||||
Basic | $ | 0.13 | $ | 0.04 | ||||
Diluted | $ | 0.12 | $ | 0.03 | ||||
Shares used in computing net income per share: | ||||||||
Basic | 47,696 | 44,529 | ||||||
Diluted | 53,638 | 48,274 | ||||||
(1) Stock-based compensation charges: | ||||||||
Cost of revenues (included) | $ | 2 | $ | 3 | ||||
(2) Other stock-based compensation charges by functional area: | ||||||||
Research and development | $ | 28 | $ | 46 | ||||
Selling, general and administrative | 73 | 68 | ||||||
$ | 101 | $ | 114 | |||||
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
4
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
(restated) | ||||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 6,224 | $ | 1,622 | ||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization | 255 | 205 | ||||||
Amortization of deferred compensation | 103 | 117 | ||||||
Tax benefits from stock option exercises | 889 | — | ||||||
Changes in assets and liabilities: | ||||||||
Accounts receivable, net | (7,759 | ) | (2,787 | ) | ||||
Inventories | (1,923 | ) | (2,831 | ) | ||||
Refundable and deferred income taxes | 1,204 | — | ||||||
Prepaid expenses and other assets | (1,124 | ) | (1,295 | ) | ||||
Accounts payable | 9,203 | 3,723 | ||||||
Accrued expenses and other liabilities | 3,995 | 148 | ||||||
Deferred income on shipments to distributors | (626 | ) | 223 | |||||
Net cash provided by (used in) operating activities | 10,441 | (875 | ) | |||||
Cash flows from investing activities: | ||||||||
Purchase of short-term investments | (5,773 | ) | — | |||||
Proceeds from sale of short-term investments | — | 2,002 | ||||||
Purchase of long-term investment | (2,009 | ) | — | |||||
Purchases of property, plant and equipment | (3,662 | ) | (1,457 | ) | ||||
Net cash provided by (used in) investing activities | (11,444 | ) | 545 | |||||
Cash flows from financing activities: | ||||||||
Proceeds from issuance of common stock, net | 115,463 | 804 | ||||||
Payment for repurchase of common stock, net | — | (1 | ) | |||||
Net cash provided by financing activities | 115,463 | 803 | ||||||
Net increase in cash and cash equivalents | 114,460 | 473 | ||||||
Cash and cash equivalents at beginning of period | 50,438 | 55,803 | ||||||
Cash and cash equivalents at end of period | $ | 164,898 | $ | 56,276 | ||||
Supplemental cash flow information: | ||||||||
Taxes paid | $ | 800 | $ | — | ||||
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
5
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Note 1 — Basis of Presentation and Restatement
Overview
The accompanying unaudited condensed consolidated financial statements as of July 31, 2003 and April 30, 2003 and for the three months ended July 31, 2003 and 2002 have been prepared by OmniVision Technologies, Inc. and subsidiaries (the “Company” or “OmniVision”) in accordance with the rules and regulations of the Securities and Exchange Commission. The amounts as of April 30, 2003 have been derived from our annual audited financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, the accompanying unaudited financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of the Company and its results of operations and cash flows. These financial statements should be read in conjunction with the annual audited financial statements and notes as of and for the year ended April 30, 2003, included in the Company’s Annual Report on Form 10-K.
On January 20, 2004, the Company announced that its Board of Directors had approved a 2-for-1 split of the Company’s common stock to be effected in the form of a stock dividend payable to stockholders of record on January 30, 2004. Stockholders of record received one additional share of common stock for every share held on January 30, 2004. The stock split was effected after the close of market on February 17, 2004 and the additional shares were distributed on February 18, 2004. All share and per share data in this Quarterly Report on Form 10-Q/A are presented on a post-stock split basis.
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Restatement of Previous Quarterly Financial Statements
On June 23, 2004, the Company issued a press release and filed a Current Report on Form 8-K announcing that the Company was restating its financial results for its quarters ended July 31, 2003, October 31, 2003 and January 31, 2004.
The restatements arose out of an internal review which was initiated in response to issues raised by an employee. The management of the Company notified the Audit Committee of the Board of Directors of the issues raised, and the Audit Committee, with assistance from special legal counsel, conducted its own independent investigation. As a result of the internal review and the independent investigation, management and the Audit Committee determined that certain errors had occurred which principally affected the timing of revenue recognition for certain sales. The independent investigation concluded that there was no evidence of wrongdoing in connection with these errors.
The restatement of the Company’s financial results for the first three quarters of fiscal 2004 related primarily to two issues identified as part of the internal review and independent investigation. First, beginning in the second half of fiscal 2003 and continuing through the first nine months of fiscal 2004, certain distribution sales, for which the Company recognizes revenue on a “sell-through” basis, were not reported to the Company by one of its distributors in a timely manner. Additionally, in the second and third quarters of fiscal 2004, during the transition of testing operations and certain international sales functions to overseas locations, some shipments made to customers late in
6
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
For the Three Months Ended July 31, 2003 and 2002
(unaudited)
the quarter were incorrectly classified as transferring title upon delivery as opposed to upon shipment, and therefore revenue was not recognized when product was shipped. Both of these issues resulted in delayed revenue recognition. Both management and the Audit Committee determined that the errors did not have material effects on quarterly or annual financial statements for fiscal 2003 and consequently decided not to restate the quarterly or annual financial results for such periods.
The following tables present amounts from operations and the balance sheet as previously reported and as restated:
Three Months Ended | ||||||||
July 31, 2003 | ||||||||
(Reported) | (Restated) | |||||||
Revenues | $ | 46,492 | $ | 46,839 | ||||
Cost of revenues(1) | 29,128 | 29,460 | ||||||
Gross profit | 17,364 | 17,379 | ||||||
Operating expenses: | ||||||||
Research and development | 3,580 | 3,580 | ||||||
Selling, general and administrative | 4,490 | 4,490 | ||||||
Stock-based compensation(2) | 101 | 101 | ||||||
Total operating expenses | 8,171 | 8,171 | ||||||
Income from operations | 9,193 | 9,208 | ||||||
Interest income, net | 222 | 222 | ||||||
Income before income taxes | 9,415 | 9,430 | ||||||
Provision for income taxes | 3,201 | 3,206 | ||||||
Net income | $ | 6,214 | $ | 6,224 | ||||
Net income per share: | ||||||||
Basic | $ | 0.13 | $ | 0.13 | ||||
Diluted | $ | 0.12 | $ | 0.12 | ||||
Shares used in computing net income per share: | ||||||||
Basic | 47,696 | 47,696 | ||||||
Diluted | 53,638 | 53,638 | ||||||
(1) Stock-based compensation included in Cost of revenues | $ | 2 | $ | 2 | ||||
(2) Stock-based compensation by functional area: | ||||||||
Research and development | $ | 28 | $ | 28 | ||||
Selling, general and administrative | 73 | 73 | ||||||
$ | 101 | $ | 101 | |||||
Balance Sheet Items: | ||||||||
Accounts Receivable, net | 26,366 | 26,892 | ||||||
Inventories | 15,897 | 15,565 | ||||||
Total Assets | 253,010 | 253,204 | ||||||
Accrued expenses and other current liabilities | 12,737 | 12,032 | ||||||
Total current liabilities | 34,687 | 33,982 | ||||||
Shareholders’ Equity | 218,323 | 219,222 |
Note 2 — Summary of Significant Accounting Policies
Revenue Recognition
The Company recognizes revenue from the sale of products to original equipment manufacturers and value added resellers upon the shipment of its products to the customer provided that the Company has received a signed purchase order, the price is fixed, title has transferred to the customer, collection of resulting receivables is considered reasonably assured, product returns are reasonably estimable, there are no customer acceptance requirements and there are no remaining significant obligations. The Company provides for future returns based on historical experiences at the time revenue is recognized. For certain shipments to distributors under agreements allowing for return or credits, revenue is deferred until the distributor resells the product to the end-user customer. Deferred income on shipment to distributors represents the amount billed less the cost of inventory shipped to but not yet sold by distributors.
7
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
For the Three Months Ended July 31, 2003 and 2002
(unaudited)
Short-term Investments
The Company’s short-term investments, which are classified as available-for-sale, are invested in high-grade corporate securities and government bonds maturing approximately twelve months or less from the date of purchase. These investments are reported at fair value which approximates cost. Unrealized gains or losses are recorded in stockholders’ equity and included in other comprehensive income (losses). Unrealized gains or losses were not significant during any period covered by these financial statements.
8
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
For the Three Months Ended July 31, 2003 and 2002
(unaudited)
Stock-Based Compensation
The Company accounts for stock-based employee compensation arrangements using the intrinsic value method in accordance with the provisions of Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB 25”) and the Financial Accounting Standards Board (“FASB”) FASB Interpretation 44, “Accounting for Certain Transactions Involving Stock Compensation” (“FIN 44”) and complies with the disclosure provisions of Statement of Financial Accounting Standards No. 123, “Accounting for Stock-Based Compensation” (“SFAS 123”), as amended by SFAS No. 148, “Accounting for Stock-Based Compensation—Transition and Disclosure—An Amendment of FASB Statement No. 123,”(“SFAS 148”). Under APB 25, compensation cost is recognized based on the difference, if any, on the date of grant between the fair value of the Company’s stock and the amount an employee must pay to acquire the stock. Deferred compensation is amortized over the vesting period on an accelerated basis using the multiple option approach as defined in paragraph 24 of FIN 28. SFAS 123 requires a “fair value” based method of accounting for an employee stock option or similar equity instrument. The following table illustrates the effect on net income and net income per share as if the Company had applied the fair value recognition provisions of SFAS 123 and SFAS 148 to stock-based employee and is referenced to in this Note as “as adjusted” (in thousands, except per share amounts):
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
(restated) | ||||||||
Net income, as reported | $ | 6,224 | $ | 1,622 | ||||
Add: Stock-based employee compensation expense included in reported net income, net of related tax effects | 38 | 79 | ||||||
Deduct: Total stock-based employee compensation determined under fair value based method for all awards, net of related tax effects | 3,105 | 1,394 | ||||||
As adjusted net income | $ | 3,157 | $ | 307 | ||||
Net income per share — Basic: | ||||||||
As reported | $ | 0.13 | $ | 0.04 | ||||
As adjusted | $ | 0.07 | $ | 0.01 | ||||
Net income per share — Diluted: | ||||||||
As reported | $ | 0.12 | $ | 0.03 | ||||
As adjusted | $ | 0.06 | $ | 0.01 | ||||
Shares used in computing net income per share — Basic: | ||||||||
As reported | 47,696 | 44,529 | ||||||
As adjusted | 47,696 | 44,529 | ||||||
Shares used in computing net income per share — Diluted: | ||||||||
As reported | 53,638 | 48,274 | ||||||
As adjusted | 50,468 | 44,844 | ||||||
The Company accounts for stock issued to non-employees in accordance with the provisions of SFAS 123 and Emerging Issues Task Force Consensus No. 96-18, “Accounting for Equity Instruments that are Offered to Other than Employees for Acquiring or in Conjunction with Selling Goods or Services” (“EITF 96-18”). Under SFAS 123 and EITF 96-18, stock option awards issued to non-employees are accounted for at their fair value, determined using the Black-Scholes option pricing model.
9
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
For the Three Months Ended July 31, 2003 and 2002
(unaudited)
Recent Accounting Pronouncements
In April 2003, the FASB issued SFAS No. 149,“Amendment of Statement 133 on Derivative Instruments and Hedging Activities.”SFAS No. 149 amends and clarifies financial accounting and reporting of derivative instruments and hedging activities under SFAS No. 133,“Accounting for Derivative Instruments and Hedging Activities.”SFAS No. 149 amends SFAS No. 133 for decisions made: (i) as part of the Derivatives Implementation Group process that require amendment to SFAS No. 133; (ii) in connection with other FASB projects dealing with financial instruments; and (iii) in connection with the implementation issues raised related to the application of the definition of a derivative. SFAS No. 149 is effective for contracts entered into or modified after June 30, 2003 and for designated hedging relationships after June 30, 2003. The adoption of SFAS No. 149 has no material impact on the Company’s financial position and results of operations.
In May 2003, the FASB issued SFAS No. 150,“Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” The Statement establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity and further requires that an issuer classify as a liability (or an asset in some circumstances) financial instruments that fall within its scope because that financial instrument embodies an obligation of the issuer. Many of such instruments were previously classified as equity. The statement is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. The Company believes that the adoption of this standard will not have a material impact on its financial position and results of operations.
10
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
For the Three Months Ended July 31, 2003 and 2002
(unaudited)
Note 3 — Balance Sheet Accounts (In Thousands)
July 31, | April 30, | |||||||
2003 | 2003 | |||||||
Cash and cash equivalents: | ||||||||
Cash | $ | 1,378 | $ | 941 | ||||
Money market funds | 103,629 | 25,363 | ||||||
Commercial paper | 59,891 | 24,134 | ||||||
$ | 164,898 | $ | 50,438 | |||||
Accounts receivable: | (restated) | |||||||
Accounts receivable | $ | 29,695 | $ | 21,188 | ||||
Less: Allowance for doubtful accounts | (1,315 | ) | (915 | ) | ||||
Sales return reserve | (1,488 | ) | (1,140 | ) | ||||
$ | 26,892 | $ | 19,133 | |||||
Inventories: | (restated) | |||||||
Work in progress | $ | 10,686 | $ | 8,942 | ||||
Finished goods | 4,879 | 4,700 | ||||||
$ | 15,565 | $ | 13,642 | |||||
Prepaid expenses and other assets: | ||||||||
Prepaid expenses | $ | 2,196 | $ | 1,187 | ||||
Other receivables | 114 | 8 | ||||||
$ | 2,310 | $ | 1,195 | |||||
Property, plant and equipment, net: | ||||||||
Building | $ | 8,432 | $ | — | ||||
Building improvements | 3,373 | — | ||||||
Machinery and equipment | 4,901 | 3,607 | ||||||
Furniture and fixtures | 201 | 283 | ||||||
Software | 1,087 | 976 | ||||||
Construction in progress | 894 | 10,986 | ||||||
18,888 | 15,852 | |||||||
Less: Accumulated depreciation and amortization | (3,025 | ) | (3,396 | ) | ||||
$ | 15,863 | $ | 12,456 | |||||
Note 4 — Net Income Per Share
Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive common shares outstanding during the period using the treasury stock method. Potentially dilutive common shares include the effect of stock options. For the three months ended July 31, 2002, 42,600 shares of common stock subject to outstanding options were not included in the calculation of diluted net income per share as they were considered antidilutive (i.e., the per share exercise price for such options exceeded the trading price of the Company’s common stock as reported on The Nasdaq Stock Market.)
11
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
For the Three Months Ended July 31, 2003 and 2002
(unaudited)
The following table sets forth the computation of basic and diluted income per share attributable to common stockholders for the periods indicated (in thousands, except per share data):
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
(restated) | ||||||||
Numerator: | ||||||||
Net income | $ | 6,224 | $ | 1,622 | ||||
Denominator: | ||||||||
Weighted average shares | 47,774 | 44,844 | ||||||
Weighted average unvested common stock subject to repurchase | (78 | ) | (315 | ) | ||||
Denominator for basic net income per share | 47,696 | 44,529 | ||||||
Effect of dilutive securities: | ||||||||
Common stock options | 5,864 | 3,430 | ||||||
Unvested common stock subject to repurchase | 78 | 315 | ||||||
Denominator for dilutive net income per share | 53,638 | 48,274 | ||||||
Basic net income per share | $ | 0.13 | $ | 0.04 | ||||
Diluted net income per share | $ | 0.12 | $ | 0.03 | ||||
In July 2003, the Company sold 6,186,452 shares of common stock in a follow-on public offering at a price of $19.38 per share for net proceeds of approximately $113.9 million. The incremental shares are reflected in the weighted average shares outstanding as of and for the three-month period ended July 31, 2003.
Note 5 — Segment, Product Line and Geographic Information
The Company identifies its operating segments based on business activities, management responsibility and geographic location. For all periods presented, the Company operated in a single business segment.
Revenues from the Company’s two product lines, digital and analog image sensors, were as follows (in thousands):
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
(restated) | ||||||||
Digital image sensors | $ | 38,461 | $ | 8,494 | ||||
Analog image sensors | 8,378 | 8,296 | ||||||
Total | $ | 46,839 | $ | 16,790 | ||||
12
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
For the Three Months Ended July 31, 2003 and 2002
(unaudited)
The Company sells its products primarily to customers in the Asia Pacific region and in the United States of America. Revenues by geographic locations are not necessarily representative of the geographic distribution of sales into end-user markets as the Company’s customers sell their products globally. The revenues by geographic locations in the following table are based on the country or region in which the customer is located (in thousands):
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
(restated) | ||||||||
Hong Kong | $ | 18,959 | $ | 7,647 | ||||
Taiwan | 15,770 | 4,142 | ||||||
China | 5,851 | 427 | ||||||
United States | 624 | 2,778 | ||||||
All other | 5,635 | 1,796 | ||||||
$ | 46,839 | $ | 16,790 | |||||
In December 2000, the Company formed a subsidiary to conduct testing operations and other processes associated with the manufacturing of its products in China. The registered capital of this subsidiary was initially $12.0 million, of which $3.8 million was funded by the Company in the fiscal year ended April 30, 2001, as required by Chinese law. The Company funded an additional $3.7 million during fiscal 2002. In August 2002, the Company increased the registered capital to $30.0 million and funded an additional $4.0 million during fiscal 2003. A total of $11.5 million of the $30.0 million of registered capital of the subsidiaries had been funded as of July 31, 2003, from the Company’s available working capital. The remaining $18.5 million of registered capital must be funded as follows; $3.2 million by January 2004, and $15.3 million by January 2005. The $11.5 million invested through July 31, 2003, was used primarily to pay for the construction of a building and associated leasehold improvements.
The Company’s long-lived assets are located in the following countries (in thousands):
July 31, | April 30, | |||||||
2003 | 2003 | |||||||
China | $ | 12,181 | $ | 8,968 | ||||
United States | 3,775 | 3,588 | ||||||
Taiwan | 4,907 | 2,845 | ||||||
All other | 241 | 278 | ||||||
$ | 21,104 | $ | 15,679 | |||||
Note 6 — Employee Stock Options and Stock Purchase Plans
Employee Stock Option Grants
Options to purchase 2,842,850 shares of common stock were granted to employees during the three months ended July 31, 2003. As of July 31, 2003, options to purchase 9,720,176 shares of common stock were outstanding.
2000 Employee Stock Purchase Plan
As of July 31, 2003, 1,351,960 shares had been purchased under the 2000 Employee Stock Purchase Plan (the “2000 Purchase Plan”).
13
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
For the Three Months Ended July 31, 2003 and 2002
(unaudited)
Fair Value Disclosures
Information regarding net income and net income per share, as adjusted, is required by SFAS 123, which also requires that the information be determined as if the Company had accounted for its employee stock options granted under the fair value method. The fair value for these options was estimated using the Black-Scholes option pricing model. The per share weighted average estimated fair value for employee options granted was $12.62 and $4.68 during the three months ended July 31, 2003 and 2002, respectively. The Black-Scholes model was developed for use in estimating the fair value of traded options that have no restrictions and are fully transferable and negotiable in a free trading market. Black-Scholes does not consider the employment, transfer or vesting restrictions that are inherent in the Company’s employee options. Use of an option valuation model, as required by SFAS 123, includes highly subjective assumptions based on long-term predictions, including the expected stock price volatility and average life of each option grant. Because the Company’s employee options have characteristics significantly different from those of freely traded options, and because changes in the subjective input assumptions can materially affect the Company’s estimate of the fair value of those options, in the Company’s opinion, the existing valuation models, including Black-Scholes, are not reliable single measures and may misstate the fair value of the Company’s employee options.
The following weighted average assumptions are included in the estimated fair value calculations for stock option grants in the three months ended July 31, 2003 and 2002:
Employee Stock Option | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
Risk-free interest rate | 1.73 | % | 2.10 | % | ||||
Expected term of options (in years) | 3.5 | 3.5 | ||||||
Expected volatility | 130.4 | % | 134.6 | % | ||||
Expected dividend yield | 0 | % | 0 | % |
Using Black-Scholes, the per share weighted average estimated fair value of rights issued pursuant to the Company’s 2000 Purchase Plan during the three months ended July 31, 2003 and 2002 was $4.48 and $3.29, respectively.
The following weighted average assumptions are included in the estimated grant date fair value calculations for rights to purchase stock under the 2000 Purchase Plan:
Employee Stock Purchase | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
Risk-free interest rate | 1.16 | % | 1.80 | % | ||||
Expected term of options (in years) | 0.5 | 0.5 | ||||||
Expected volatility | 130.4 | % | 134.6 | % | ||||
Expected dividend yield | 0 | % | 0 | % |
Note 7 — Commitments and Contingencies
From time to time, the Company has been subject to legal proceedings and claims with respect to such matters as patents, product liabilities and other actions arising out of the normal course of business.
On November 29, 2001, a complaint captioned McKee v. OmniVision Technologies, Inc., et. al., Civil Action No. 01 CV 10775, was filed in the United States District Court for the Southern District of New York against
14
Table of Contents
OMNIVISION TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
For the Three Months Ended July 31, 2003 and 2002
(unaudited)
OmniVision, some of the Company’s directors and officers, and various underwriters for the Company’s initial public offering. Plaintiffs generally allege that the named defendants violated federal securities laws because the prospectus related to the Company’s offering failed to disclose, and contained false and misleading statements regarding, certain commissions purported to have been received by the underwriters, and other purported underwriter practices in connection with their allocation of shares in the Company’s offering. The complaint seeks unspecified damages on behalf of a purported class of purchasers of the Company’s common stock between July 14, 2000 and December 6, 2000. Substantially similar actions have been filed concerning the initial public offerings for more than 300 different issuers, and the cases have been coordinated as In re Initial Public Offering Securities Litigation, 21 MC 92. The Company’s directors and officers have been dismissed without prejudice pursuant to a stipulation. On February 19, 2003, the Court granted in part and denied in part a motion to dismiss brought by defendants including OmniVision. The order dismisses all claims against the Company except for a claim brought under Section 11 of the Securities Act of 1933. A proposal has been made for the settlement and release of claims against the issuer defendants, including OmniVision. The settlement is subject to a number of conditions, including approval of the proposed settling parties and the Court. If the settlement does not occur, and litigation against the Company continues, the Company believes that it has meritorious defenses and intends to defend the case vigorously.
On August 21, 2002 the Company initiated a patent infringement action in Taiwan, R.O.C. against IC Media Corporation of San Jose, CA for infringement of Taiwan patent NI-139439 owned by OmniVision. The action was brought in the Civil Tribunal of the Shih Lin District Court and assigned Civil Action Number 91 Su-Zi 1074. The patent infringement action seeks damages and injunctive relief against IC Media Corporation. In response to the Company’s patent infringement action, on October 2, 2002, IC Media Corporation initiated a cancellation proceeding (Cancellation No. 089123560N01) in the Taiwan Intellectual Property Office with respect to the Company’s Taiwan patent NI-139439. On July 23, 2003, the Taiwan Intellectual Property Office made an initial determination to grant the cancellation of Taiwan patent NI-139439. On August 22, 2003, OmniVision appealed the decision of the Taiwan Intellectual Property Office to the Taiwan Ministry of Economic Affairs.
On June 30, 2003, Mr. Chia-Chin Ku filed a complaint in Santa Clara County Superior Court against the Company and its president and chief executive officer, Mr. Shaw Hong. The complaint alleges that, by forming OmniVision in 1995, Mr. Hong breached a fiduciary duty owed to HK Technology, Inc., a privately-held corporation Mr. Hong and others founded in 1988. The complaint further alleges that the Company “misappropriated and converted” assets and technology belonging to HK Technology, Inc. The complaint seeks damages in an unspecified amount. The Company believes that it has meritorious defenses to the allegations and claims and intends to defend itself vigorously. The Company understands that HK Technology, Inc. has not engaged in significant substantive operations since the early 1990s. The Company also understands that HK Technology Inc.’s primary line of business was the design of chipsets for personal computers, and that it did not engage in any business concerning image sensors, which is OmniVision’s primary line of business. The Company does not believe that OmniVision’s technology or products incorporate or use any proprietary technology of HK Technology, Inc.
On July 14, 2003, Sunex, Inc. filed a complaint against OmniVision in San Diego County Superior Court. Sunex was a supplier of optical lenses and lens holders for one of the Company’s cell phone products. Under its complaint, Sunex is seeking to recover approximately $1.8 million plus interest and attorney’s fees. Sunex’s complaint relates to parts delivered by Sunex to OmniVision in the quarter ended April 30, 2003 and the Company’s cancellation in that quarter of additional purchase orders it had previously placed with Sunex. The Company intends to defend itself vigorously and has filed a counterclaim against Sunex in which the Company alleges breach of contract and breach of warranties, and seeks damages in an amount yet to be determined. The Company believes that any amount it may ultimately owe Sunex in excess of the amount it had accrued as of April 30, 2003 will not have a material adverse affect on its financial condition or results of operation.
15
Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 which involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors that include, but are not limited to, the risks discussed in “Factors Affecting Future Results.” These forward-looking statements include, but are not limited to: the statements relating to the completion of the consolidation of our testing operations in China, the expansion of the scope of our operations at our Chinese facility and the expansion of our testing capabilities in the seventh paragraph under “Overview;” the statements relating to maintaining our position as a leader in CMOS sensor technology in the eighth paragraph under “Overview;” the statements relating to the future revenues from sales of CameraChips for digital applications in the third paragraph under “Revenues;” the statements relating to our gross margin during the remainder of fiscal 2004 in the first paragraph under “Gross Profit;” the statements relating to research and development expenses during the remainder of fiscal 2004 in the second paragraph under “Research and Development;” the statements relating to future selling, general and administrative expenses in the second paragraph under “Selling, General and Administrative;” the statements relating to the expected effective tax rate for fiscal 2004 under “Provision for Income Taxes;” the statements relating to the expected effect of our contractual obligations and commercial commitments on our liquidity and cash flows in future periods in the first paragraph under “Contractual Obligations and Commercial Commitments;” the statements relating to the consolidation of our testing operations in China, the expansion of the scope of our operations at our Chinese facility, the expansion of our testing capabilities, the funding of the capital commitment to our Chinese subsidiary, third party financing, the issuance of equity securities and the issuance of debt securities in the second paragraph under “Contractual Obligations and Commercial Commitments;” the statements relating to cash resources available to meet capital requirements in the third paragraph under “Contractual Obligations and Commercial Commitments;” the statements relating to the effect of and exposure to foreign currency exchange rate risk under “Foreign Currency Exchange Risk;” the statements relating to the effect of and exposure to market interest rate risk under “Quantitative and Qualitative Discussion of Market Interest Rate Risk;” the statements relating to our expectation of the ability of our disclosure controls and procedures to prevent errors in the first paragraph under “Controls and Procedures;” and the statements relating to the affect that the implementation of a new enterprise resource planning system will have on our internal controls in the fourth paragraph under “Controls and Procedures;” among others. These forward-looking statements are based on current expectations and entail various risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. Such risks and uncertainties are set forth below under “Factors Affecting Future Results.” All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by such factors.
Recent Events and Restatement
We have restated our financial statements for the first, second and third quarters of fiscal 2004. We have filed Form 10-Q/As for each of these quarters to reflect the restatement of the financial information for such periods.
The restatements arose out of an internal review which was initiated in response to issues raised by an employee. We notified the Audit Committee of the Board of Directors of the issues raised, and the Audit Committee, with assistance from special legal counsel, conducted its own independent investigation. As a result of the internal review and the independent investigation, management and the Audit Committee determined that certain errors had occurred which principally affected the timing of revenue recognition for certain sales. The independent investigation concluded that there was no evidence of wrongdoing in connection with these errors.
The restatement of our financial results for the first three quarters of fiscal 2004 related primarily to two issues identified as part of the internal review and independent investigation. First, beginning in the second half of fiscal 2003 and continuing through the first nine months of fiscal 2004, certain distribution sales, for which we recognize revenue on a “sell-through” basis, were not reported to us by one of our distributors in a timely manner. Additionally, in the second and third quarters of fiscal 2004, during the transition of testing operations and certain international sales functions to overseas locations, some shipments made to customers late in the quarter were incorrectly classified as transferring title upon delivery as opposed to upon shipment, and therefore revenue was not recognized when product was shipped. Both of these issues resulted in delayed revenue recognition. Both management and the Audit Committee determined that the errors did not have material effects on quarterly or annual
16
Table of Contents
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued) |
financial statements for fiscal 2003 and, consequently, decided not to restate the quarterly or annual financial results for such periods.
Overview
We design, develop and market high performance, highly integrated and cost efficient semiconductor image sensor devices. Our main product, an image sensing device called the CameraChip™, is used to capture an image in a number of consumer and commercial mass market applications. Our CameraChips are designed to use the complementary metal oxide semiconductor, or CMOS, fabrication process. We have designed our CameraChip as a single chip solution that integrates several distinct functions including image capture, image processing, color processing and the conversion and output of a fully processed image or video stream. Our highly integrated CMOS CameraChips help enable mass market camera device manufacturers to build camera applications that generally have high image quality and resolution, are low cost, small in size, and consume low amounts of power.
Our CameraChips are currently used in a number of consumer applications including digital still and video cameras, cell phones, personal computers and toys and games such as interactive video games.
Our CameraChips are sold to customers who incorporate them in either digital or analog mass market applications. Some examples of digital mass market applications that currently incorporate our CameraChips are digital still cameras, cell phone cameras and personal computer camera applications. Some examples of analog applications that currently incorporate our CameraChips are security and surveillance cameras and toy cameras.
We sell our products worldwide by a direct sales force to original equipment manufacturers, or OEMs, which include branded customers and contract manufacturers, and value added resellers, or VARs, and indirectly through distributors.
We currently outsource the wafer fabrication, color filter application and packaging of our CameraChip products. This approach allows us to focus our resources on the design, development and marketing of our products and significantly reduces our capital requirements.
We have designed and developed a complete PC-based system for the testing of our CameraChips. This system has automatic handling capability, an image source, a lighting and lens system and automatic output sorting capability. We believe that this proprietary testing process helps us to reduce our testing costs, maintain consistent product quality, and identify areas for continued improvement in product quality.
We have initiated the process of consolidating our global testing operations at our Chinese subsidiary. As part of this consolidation, we have begun to relocate our automated image testing equipment from the United States to China. We anticipate that we will substantially complete this transition prior to the end of fiscal 2004. In addition, over approximately the next 18 months, we anticipate expanding the scope of our operations at our Chinese facility to include other processes associated with the manufacture of our products, such as color filter applications and sensor packaging. We also expect to expand our testing capabilities with additional automated testing equipment, which also will be located in China.
We intend to maintain our position as a leader in CMOS sensor technology by continuing to develop our core technology through our in-house research and development efforts.
In July 2003, we sold 6,186,452 shares of common stock at a price of $19.38 per share for net proceeds of approximately $113.9 million.
As of July 31, 2003, we had $164.9 million in cash and cash equivalents and $16.0 million in short-term investments. To mitigate credit risk related to short-term investments, we have an investment policy to preserve the value of capital and generate interest income from these investments without undue exposure to market fluctuations. Market risk is the potential loss due to the change in value of a financial instrument due to changes in interest rates or bond prices. Our policy is to invest in financial instruments with short durations, limiting interest rate exposure, and to measure performance against comparable benchmarks. We maintain our portfolio of cash equivalents and short-
17
Table of Contents
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued) |
term investments in a variety of securities, including both government and corporate obligations with ratings of A or better and money market funds.
Critical Accounting Policies
For a discussion of the critical accounting policies, please see the discussion in our Annual Report on Form 10-K for the fiscal year ended April 30, 2003.
Results of Operations, 2004 periods as restated, see Note 1
The following table sets forth the results of our operations as a percentage of revenues. Our historical operating results are not necessarily indicative of the results for any future period.
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
Revenues | 100.0 | % | 100.0 | % | ||||
Cost of revenues | 62.9 | 61.2 | ||||||
Gross profit | 37.1 | 38.8 | ||||||
Operating expenses: | ||||||||
Research and development | 7.7 | 15.6 | ||||||
Selling, general and administrative | 9.6 | 12.4 | ||||||
Stock compensation charge | 0.2 | 0.7 | ||||||
Total operating expenses | 17.5 | 28.7 | ||||||
Income from operations | 19.6 | 10.1 | ||||||
Interest income, net | 0.5 | 1.3 | ||||||
Income before income taxes | 20.1 | 11.4 | ||||||
Provision for income taxes | 6.8 | 1.7 | ||||||
Net income | 13.3 | % | 9.7 | % | ||||
Three Months Ended July 31, 2003 as Compared to Three Months Ended July 31, 2002
Revenues, 2004 periods as restated, see Note 1
We derive revenues from the sale of our CameraChip products for use in a wide variety of consumer and commercial mass market applications including digital still cameras, cell phones, video game consoles and security and surveillance cameras. Revenues for the three months ended July 31, 2003 and 2002 were approximately $46.8 million and $16.8 million, respectively.
18
Table of Contents
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued) |
Revenues from Sales of CameraChips for Digital as Compared to Analog Applications.
Our CameraChips are sold to customers who incorporate them into either digital or analog applications. Examples of digital applications that incorporate our CameraChips are digital still cameras, cellular phone cameras, personal computer camera applications and digital toy cameras. Examples of analog applications that incorporate our CameraChips are security and surveillance cameras and toy cameras. We sell a large portion of our products through VARs and distributors and often we do not know the identity of the manufacturer who is embedding our CameraChips into their products. As a result of our sales to VARs and distributors and because our CameraChips can be used in a wide variety of digital or analog products, we cannot accurately confirm the distribution of our revenues across specific product categories. However, we are able to confirm the distribution of our revenues by digital and analog product categories and they are as follows (in thousands):
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
Digital image sensors | $ | 38,461 | $ | 8,494 | ||||
Analog image sensors | 8,378 | 8,296 | ||||||
Total | $ | 46,839 | $ | 16,790 | ||||
Digital Revenues. Revenues from sales of CameraChips for digital applications increased 352.8% to approximately $38.5 million for the three months ended July 31, 2003 from $8.5 million for the three months ended July 31, 2002 and represented 82.1% and 50.6% of our revenues in the three months ended July 31, 2003 and 2002, respectively. This increase in revenue from sales of CameraChips for digital image sensor applications was due to increased unit sales. We believe this increase resulted from heightened demand for CameraChips designed for digital still cameras, toys and games, partially offset by a slight decrease in the revenues from the cell phone market as a result of the transition from attachment cameras to embedded cameras. We expect our revenue from sales of our CameraChips for digital applications will increase in the second quarter fiscal 2004 primarily as a result of increased sales of CMOS image sensors in the digital still camera markets, cell phones with embedded cameras and video games incorporating camera devices.
Analog Revenues. Revenues from sales of CameraChips for analog applications increased 1.0% to approximately $8.4 million for the three months ended July 31, 2003 from $8.3 million for the three months ended July 31, 2002 and represented 17.9% and 49.4% of our revenues in the three months ended July 31, 2003 and 2002, respectively. We believe this decrease in sales of CameraChips for analog image sensor applications was due primarily to decreased demand for our CameraChips for use in security surveillance cameras.
Revenues from Sales to OEMs and VARs as Compared to Distributors
We sell our CameraChips either directly to OEMs and VARs or through distributors. The following table illustrates the percentage of revenues from sales to OEMs and VARs as compared to distributors in each of the three months ended July 31, 2003 and 2002:
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
OEMs and VARs | 60.8 | % | 59.7 | % | ||||
Distributors | 39.2 | 40.3 | ||||||
Total | 100.0 | % | 100.0 | % | ||||
OEMs and VARs. In the three months ended July 31, 2003 and 2002, no single OEM or VAR customer accounted for more than 10% of our revenues.
19
Table of Contents
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued) |
Revenues from Distributors. In the three months ended July 31, 2003, our only distributor customer that accounted for more than 10% of our revenues was World Peace Industrial Co. Ltd., or World Peace, headquartered in Taiwan, which accounted for approximately 28.6% of revenues. This revenue figure for sales to World Peace includes purchases by World Peace’s subsidiary, GainTune based in Hong Kong. For the three months ended July 31, 2003, no other distributor customer accounted for 10% or more of our revenues. Our largest distributor during the three months ended July 31, 2002 was World Peace, which accounted for 24.4% of revenues including sales to World Peace’s subsidiary, GainTune. For the three months ended July 31, 2002, no other distributor customer accounted for 10% or more of our revenues.
Revenues from Domestic Sales as Compared to Foreign Sales
The following table illustrates the percentage of revenues from sales of our CameraChip products to domestic customers as compared to foreign customers for the three months ended July 31, 2003 and 2002:
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
Domestic sales | 1.3 | % | 16.6 | % | ||||
Foreign sales | 98.7 | 83.4 | ||||||
Total | 100.0 | % | 100.0 | % | ||||
The majority of our foreign sales are attributable to sales made to customers in Asia and, to a lesser extent, in Europe. Over time, our sales to Asia-Pacific customers have increased primarily as a result of the continuing trend of outsourcing production to Asian manufacturers and facilities. Because of the preponderance of Asia-Pacific manufacturers and the fact that virtually all products incorporating our CameraChips are sold globally, we believe that such figures do not accurately reflect geographic distribution of sales of our products into end-user markets.
Gross Profit, 2004 periods as restated, see Note 1
Gross margins for the three months ended July 31, 2003 and 2002 were 37.1% and 38.8% of revenues, respectively. The decrease in gross margin for the three months ended July 31, 2003, as compared to the similar period in the prior year, was primarily due to a reduction in sales of previously written-off inventory, as well as to a shift in product mix in the cell phone market from sensor arrays sold in chip form to module-based products, which typically carry lower gross margins. The module-based product is sold with respect to cell phone applications. For the three months ended July 31, 2003, approximately $0.3 million of the margin was attributable to gross profit from the sale of previously written-off inventory. Excluding the revenues and gross profit from the sale of the written-off inventory, the gross margin for the three months ended July 31, 2003 would have been approximately 36.7% of revenues as compared to 35.8% of revenues during the similar period in the prior year. Excluding the impact of any sales of previously written-off inventory, we expect our gross margin during the remainder of fiscal 2004 to remain relatively stable as compared to the similar period in fiscal 2003.
20
Table of Contents
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued) |
The following table summarizes the effect of sales of previously written-off inventory on our gross profits for the three months ended July 31, 2003 and 2002 (in thousands):
Three Months Ended | ||||||||
July 31, | ||||||||
2003 | 2002 | |||||||
Sales of all products | $ | 46,839 | $ | 16,790 | ||||
Gross profit | $ | 17,379 | $ | 6,516 | ||||
Gross margin | 37.1 | % | 38.8 | % | ||||
Sales excluding products for which the costs were previously written off | $ | 46,506 | $ | 15,995 | ||||
Gross profit excluding the effect of sales of products for which the costs were previously written off | $ | 17,046 | $ | 5,721 | ||||
Gross margin excluding the effect of sales of products for which the costs were previously written off | 36.7 | % | 35.8 | % |
Research and Development
Research and development expenses consist primarily of compensation and personnel related expenses and costs for purchased materials, designs and tooling, depreciation of computers and workstations, and amortization of computer aided design software, all of which may fluctuate significantly from period to period as a result of our product development cycles. Research and development expenses for the three months ended July 31, 2003 and 2002 were approximately $3.6 million and $2.6 million, respectively. As a percentage of revenues, research and development expenses for the three months ended July 31, 2003 and 2002 represented 7.7% and 15.6%, respectively.
The increase on an absolute dollar basis in research and development of approximately $1.0 million for the three months ended July 31, 2003 from the similar period in the prior year resulted primarily from a $0.4 million increase in salary and payroll-related expenses associated with additional personnel and $0.3 million in expenses related to new product development required to improve our current product line and support new product introductions. Examples of new product development expenses include tape-out and prototype runs with our wafer manufacturers. Research and development expenses also increased for the three month period ended July 31, 2003 due to a $0.1 million increase in patent prosecution related expenses. The decline in research and development as a percentage of revenues was due to the proportionately greater increase in revenues for the three months ended July 31, 2003 from levels in the prior year. We expect research and development expenses to increase in absolute dollars in the remainder of fiscal 2004 as we develop our next generation of CameraChip products and as we continue to grow our business, including our research and development team.
Selling, General and Administrative
Selling, general and administrative expenses consist primarily of compensation and personnel related expenses, commissions paid to distributors and manufacturers’ representatives, and insurance and legal expenses. Selling, general and administrative expenses include the expenses associated with the startup of our Chinese subsidiary. Selling, general and administrative expenses for the three months ended July 31, 2003 and 2002 were approximately $4.5 million and $2.1 million, respectively. As a percentage of revenues, selling, general and administrative expenses for the three months ended July 31, 2003 and 2002 represented 9.6% and 12.4%, respectively.
The increase on an absolute dollar basis in selling, general and administrative expenses of approximately $2.4 million for the three months ended July 31, 2003 from the similar period in the prior year resulted primarily from a $0.8 million increase in commissions associated with increased revenues, a $0.7 million increase in employment expenses, a $0.5 million increase in legal and accounting expenses and a $0.4 million increase in provisions for bad debts related to the increase in accounts receivable. Selling, general and administrative expenses decreased as a percentage of revenues the three months ended July 31, 2003 as compared to the similar period in the prior year as a result of the proportionately greater increase in revenues. We expect that our future selling, general and administrative expenses will increase in absolute dollars as we continue to grow our business. In particular, we
21
Table of Contents
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued) |
expect our selling, general and administrative expenses will increase in absolute dollars in the remainder of fiscal 2004, partly as a result of increased litigation expenses and as a result of personnel additions to support our expanding organization.
Interest Income, Net
Our cash, cash equivalents and short-term and long-term investments are invested in interest-bearing accounts consisting primarily of money market accounts and high-grade corporate securities and government bonds maturing approximately twelve months or less from the date of purchase. Interest income, net, remained stable for both the three months ended July 31, 2003 and 2002 at approximately $0.2 million.
Provision for Income Taxes, 2004 periods as restated, see Note 1
We generated approximately $9.4 million and $1.9 million in income before income taxes for the three months ended July 31, 2003 and 2002, respectively. We recorded a provision for income taxes for the three months ended July 31, 2003 and 2002 of approximately $3.2 million and $0.3 million, respectively. We expect the effective tax rate for fiscal 2004 will increase as compared to fiscal 2003 but will be less than the combined federal and state statutory rate. The increase in rate is due to the anticipated mix of income between domestic and foreign entities for the fiscal year. Achieving an effective tax rate in fiscal 2004 that is less than the combined federal and state statutory rates is principally contingent upon our foreign affiliates generating income.
Liquidity and Capital Resources, 2004 periods as restated, see Note 1
Principal sources of liquidity at July 31, 2003 consisted of cash, cash equivalents and short-term investments of $180.9 million.
Our working capital increased by approximately $117.2 million to $198.1 million as of July 31, 2003 from $80.9 million as of April 30, 2003. The increase was primarily attributable to a $114.5 million increase in cash and cash equivalents principally resulting from our follow-on public offering of common stock in July 2003, a $7.8 million increase in accounts receivable, net, consistent with the increase in revenues from prior year levels during the three months ended July 31, 2003, a $5.8 million increase in short-term investments, a $1.9 million increase in inventories to support future sales and a $1.1 million increase in prepaid expenses and other assets, partially offset by a $9.2 million increase in accounts payable, and a $4.0 million increase in accrued expenses and other liabilities to support increased levels of operations. The $7.8 million increase in accounts receivable, net, reflects the higher level of sales during the three months ended July 31, 2003 and an increase in days sales outstanding to 52 days as of July 31, 2003 from 43 days as of April 30, 2003. The $1.9 million increase in inventories is attributable to higher inventory levels to support future sales. Inventory turns, calculated based on the fiscal quarters ended July 31, 2003 and April 30, 2003, remained relatively stable at 7.6 as of July 31, 2003 as compared to 7.2 as of April 30, 2003.
For the three months ended July 31, 2003, net cash provided by operating activities totaled approximately $10.4 million as compared to our use of cash for operating activities of $0.9 million for the similar period in the prior year, primarily due to net income of approximately $6.2 million for the three months ended July 31, 2003 as compared to $1.6 million for the similar period in the prior year, a $9.2 million increase in accounts payable, a $4.0 million increase in accrued expenses and other liabilities, and a $1.2 million decrease in refundable and deferred income taxes, which were partially offset by a $7.8 million increase in accounts receivable, net, a $1.9 million increase in inventories to support future sales and a $1.1 million increase in prepaid expenses and other assets.
For the three months ended July 31, 2003, our cash used in investing activities increased to approximately $11.4 million from cash provided by investing activities of $0.5 million for the similar prior year period, due to $7.8 million in purchases of short-term and long-term investments and $3.7 million in purchases of property, plant and equipment. Net cash provided by investing activities of $0.5 million for the three months ended July 31, 2002, resulted from $2.0 million in proceeds from the sale of short-term investments, partially offset by $1.5 million in purchases of property, plant and equipment.
22
Table of Contents
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued) |
For the three months ended July 31, 2003, net cash provided by financing activities increased to approximately $115.5 million from $0.8 million for the similar prior year period. The increase was primarily due to approximately $113.9 million in net proceeds resulting from our follow-on public offering of common stock in July 2003 and $1.6 million in proceeds from the issuance and sale of common stock pursuant to the exercise of stock options and from employee purchases through the employee stock purchase plan during the three months ended July 31, 2003 as compared to $0.8 million for the similar period in the prior year.
In June 2003, we purchased approximately 27% of the equity of a privately held company based in Taiwan for a total of $2.0 million in cash. The Taiwan company provides plastic packaging services and we will be a major customer. We will account for this investment using the equity method.
Contractual Obligations and Commercial Commitments
The following summarizes our contractual obligations and commercial commitments as of July 31, 2003 and the effect such obligations and commitments are expected to have on our liquidity and cash flows in future periods (in thousands):
Less than | After | |||||||||||||||||||
Total | 1 Year | 1 - 3 Years | 4 - 5 Years | 5 Years | ||||||||||||||||
Contractual Obligations | ||||||||||||||||||||
Operating leases | $ | 4,686 | $ | 1,051 | $ | 2,342 | $ | 839 | $ | 454 | ||||||||||
Noncancelable orders | 46,873 | 46,873 | — | — | — | |||||||||||||||
Total contractual obligations | 51,559 | 47,924 | 2,342 | 839 | 454 | |||||||||||||||
Other Commercial Commitments | ||||||||||||||||||||
Investment in China | 18,500 | 3,200 | 15,300 | — | — | |||||||||||||||
Total contractual obligations and commercial commitments | $ | 70,059 | $ | 51,124 | $ | 17,642 | $ | 839 | $ | 454 | ||||||||||
The $18.5 million commercial commitment referenced in the table above relates to the remaining $18.5 million of registered capital for our Chinese subsidiary. We established this subsidiary as part of our efforts to reduce the costs associated with the testing of our CameraChips. We have initiated the process of consolidating our global testing operations at our Chinese subsidiary. As part of this consolidation, we have begun to relocate our automated image testing equipment from the United States to China. We anticipate that we will substantially complete this transition prior to the end of fiscal 2004. In addition, over approximately the next 18 months, we anticipate expanding the scope of our operations at our Chinese facility to include other processes associated with the manufacture of our products, such as color filter applications and sensor packaging. We also expect to expand our testing capabilities with additional automated testing equipment, which also will be located in China. We expect to fund the capital commitment to our Chinese subsidiary through a combination of funds invested from our available working capital or by investments from third parties. Third party financing could include debt financing from banking institutions or an equity financing transaction. Third party financing may not be available to us when and as required or on terms that are favorable to our stockholders and us. In the event we are unable to obtain financing from third parties, the issuance of our equity securities, including securities convertible into our equity securities, would dilute the ownership interests of our existing stockholders and the issuance of debt securities could increase the risk or perceived risk of our business. Issuance of debt securities could also impair our financial condition and interest payments could have an adverse effect on our results of operation.
We currently expect our available cash, cash equivalents, and short-term investments, together with cash that we anticipate to be generated from business operations, to be sufficient to satisfy our foreseeable working capital requirements. Our ability to generate cash from operations is subject to substantial risks described below under the caption“Factors Affecting Future Results.”We encourage you to review these risks carefully. If we are unable to generate sufficient cash from our operations, it would have a material adverse effect on our business and financial condition.
23
Table of Contents
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued) |
Factors Affecting Future Results
This Quarterly Report on Form 10-Q, including this Management’s Discussion and Analysis, contains forward-looking statements. These forward-looking statements are subject to substantial risks and uncertainties that could cause our future business, financial condition or results of operations to differ materially from our historical results or currently anticipated results. For the most recent description of the risks and uncertainties we face, please see “Factors Affecting Future Results” in Item 7 of our Annual Report on Form 10-K for the fiscal year ended April 30, 2004, which Annual Report is being filed with the SEC as of the same date as this amended Quarterly Report on Form 10-Q.
24
Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Foreign Currency Exchange Risk
We are an international company, selling our products globally, in particular, to branded customers, contract manufacturers, VARs and distributors in China, Hong Kong, Japan, Korea and Taiwan. Although we transact our business in U.S. dollars, future fluctuations in the value of the U.S. dollar may affect the competitiveness of our products, gross profits realized, and results of operations. Further, we incur expenses in Japan, Korea, Taiwan, Thailand, China and other countries that are denominated in currencies other than the U.S. dollar. We cannot estimate the effect that an immediate 10% change in foreign currency exchange rates would have on our future operating results or cash flows as a direct result of changes in exchange rates. However, we do not believe that we currently have any significant direct foreign currency exchange rate risk, and we have not hedged exposures denominated in foreign currencies or any other derivative financial instruments.
Quantitative and Qualitative Discussion of Market Interest Rate Risk
Our cash equivalents and short-term investments are exposed to financial market risk due to fluctuation in interest rates, which may affect our interest income and, in the future, the fair market value of our investments. We manage our exposure to financial market risk by performing ongoing evaluations of our investment portfolio. We presently invest in short term bank market rate accounts, certificates of deposit issued by banks, high-grade corporate securities and government bonds maturing approximately 12 months or less from the date of purchase. Due to the short maturities of our investments, the carrying value should approximate the fair market value. In addition, we do not use our investments for trading or other speculative purposes. Due to the short duration of our investment portfolio, we do not expect that an immediate 10% change in interest rates would have a material effect on the fair market value of our portfolio. Therefore, we would not expect our operating results or cash flows to be affected to any significant degree by the effect of a sudden change in market interest rates.
ITEM 4. CONTROLS AND PROCEDURES
(a) Evaluation of Disclosure Controls and Procedures (as of the date of filing this amended Quarterly Report on Form 10-Q)
We have restated our financial results for the quarters ended July 31, 2003, October 31, 2003 and January 31, 2004 to reflect adjustments to our previously reported financial information. The restatements arose out of an internal review which was initiated in response to issues raised by an employee. We notified the Audit Committee of the Board of Directors of the issues raised, and the Audit Committee, with assistance from special legal counsel, conducted its own independent investigation. As a result of the internal review and the independent investigation, management and the Audit Committee determined that certain errors had occurred which principally affected the timing of revenue recognition for certain sales. The independent investigation concluded that there was no evidence of wrongdoing in connection with these errors.
The restatement of our financial results for the first three quarters of fiscal 2004 related primarily to two issues identified as part of the internal review and independent investigation. First, beginning in the second half of fiscal 2003 and continuing through the first nine months of fiscal 2004, certain distribution sales, for which we recognize revenue on a “sell-through” basis, were not reported to us by one of our distributors in a timely manner. Additionally, in the second and third quarters of fiscal 2004, during the transition of testing operations and certain international sales functions to overseas locations, some shipments made to customers late in the quarter were incorrectly classified as transferring title upon delivery as opposed to upon shipment, and therefore revenue was not recognized when product was shipped. Both of these issues resulted in delayed revenue recognition.
Partly in connection with the restatement of our financial statements for the first, second and third quarters for fiscal 2004, our Independent Registered Public Accounting Firm have identified material weaknesses in our internal controls and procedures relating to errors in our recognition of revenue resulting from incorrectly reviewing distributor reports and from incorrectly applying revenue recognition policies in accordance with title transfer, risk of loss and related shipping terms. Our Independent Registered Public Accounting Firm also noted a material weakness related to our need to increase our financial reporting and accounting staffing levels to ensure that we can meet our financial reporting obligations given the significant growth in our business in recent periods. In addition, our Independent Registered Public Accounting Firm reported additional observations and recommendations with respect to our financial reporting and internal controls. Correcting the identified material weaknesses and addressing the other issues identified by our Independent Registered Public Accounting Firm, responding to the findings of the internal review and the independent investigation and continuously strengthening our internal controls and financial reporting capabilities are some of our highest priorities. We have adopted and implemented measures to ensure that information required to be disclosed in this amended Quarterly Report on Form 10-Q has been recorded, processed, summarized and reported accurately, and we continue to adopt and implement, several measures in connection with our ongoing efforts to improve our control processes and corporate governance in response to the issues identified in the internal review, independent investigation and the report of our Independent Registered Public Accounting Firm. These measures include the following:
• | Working in cooperation with the distributor who did not report resales of our CameraChips on a timely basis to receive sell-through data from such distributor for the full quarterly period. | |||
• | Additional training of our sales and marketing staff and our financial reporting and accounting staff to be particularly attentive to reviewing distributor reports to prevent revenue recognition errors from occurring. | |||
• | Additional training of our sales and marketing staff and our financial reporting and accounting staff as to be particularly attentive to the terms of purchase orders, including matters related to title transfer, risk of loss and related shipping terms, to prevent revenue recognition errors from occurring. |
25
Table of Contents
• | Augmenting our internal control and financial reporting staff, both domestically and abroad, to help ensure that we can adequately meet our financial reporting responsibilities as our business continues to grow. | |||
• | Improving the documentation of our internal controls. | |||
• | Improving our IT infrastructure on an enterprise-wide basis. |
We believe that we have addressed the specific accounting issues identified in the internal review and independent investigation. In addition, we believe we have improved, and are in the process of further improving, our infrastructure, personnel, processes and controls to help ensure that we are able to produce accurate financial statements on a timely basis. However, our growth in operations will continue to place a strain on our management systems, controls and resources. To address these issues, we will need to continue to improve our financial and managerial controls, reporting systems and procedures in the future and will need to continue to expand, train and manage our work force company-wide, including the size of our accounting and financial reporting staff. If we are unable to maintain an adequate level of financial processes and controls, we may not be able to accurately report our financial performance on a timely basis and our business and stock price would be harmed.
While we continue to enhance our internal controls and procedures, we have instituted disclosure controls and procedures that are designed to ensure that the information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure based closely on the definition of “disclosure controls and procedures” in Rule 13a-14(c). In designing and evaluating the disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures in reaching that level of reasonable assurance. Because of inherent limitations in any system of disclosure controls and procedures, no evaluation of controls can provide absolute assurance that all instances of error or fraud, if any, within our company may be detected.
Our management carried out an evaluation, with the participation of our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that, as of both July 31, 2003, the end of our first quarter of fiscal 2004 and April 30, 2004, the end of fiscal 2004, our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and 15d-15(e) promulgated under the Exchange Act, are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms.
26
Table of Contents
(b) Changes in Internal Controls
Other than as described above, there have been no significant changes in our internal controls or in other factors that could significantly affect the internal controls subsequent to the date that we completed our evaluation.
We are continuing to implement modules in our enterprise resource planning system, which we have started in 2003. We believe that we have adequate backup procedures and systems in place such that the process of implementing this enterprise resource planning system will not materially a adversely affect our internal controls.
27
Table of Contents
PART II — OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
On November 29, 2001, a complaint captioned McKee v. OmniVision Technologies, Inc., et. al., Civil Action No. 01 CV 10775, was filed in the United States District Court for the Southern District of New York against OmniVision, some of our directors and officers, and various underwriters for our initial public offering. Plaintiffs generally allege that the named defendants violated federal securities laws because the prospectus related to our offering failed to disclose, and contained false and misleading statements regarding, certain commissions purported to have been received by the underwriters, and other purported underwriter practices in connection with their allocation of shares in our offering. The complaint seeks unspecified damages on behalf of a purported class of purchasers of our common stock between July 14, 2000 and December 6, 2000. Substantially similar actions have been filed concerning the initial public offerings for more than 300 different issuers, and the cases have been coordinated as In re Initial Public Offering Securities Litigation, 21 MC 92. Our directors and officers have been dismissed without prejudice pursuant to a stipulation. On February 19, 2003, the Court granted in part and denied in part a motion to dismiss brought by defendants including OmniVision. The order dismisses all claims against us except for a claim brought under Section 11 of the Securities Act of 1933. A proposal has been made for the settlement and release of claims against the issuer defendants, including OmniVision. The settlement is subject to a number of conditions, including approval of the proposed settling parties and the Court. If the settlement does not occur, and litigation against us continues, we believe we have meritorious defenses and intend to defend the case vigorously.
On August 21, 2002 we initiated a patent infringement action in Taiwan, R.O.C. against IC Media Corporation of San Jose, CA for infringement of Taiwan patent NI-139439 owned by OmniVision. The action was brought in the Civil Tribunal of the Shih Lin District Court and assigned Civil Action Number 91 Su-Zi 1074. The patent infringement action seeks damages and injunctive relief against IC Media Corporation. In response to our patent infringement action, on October 2, 2002, IC Media Corporation initiated a cancellation proceeding (Cancellation No. 089123560N01) in the Taiwan Intellectual Property Office with respect to our Taiwan patent NI-139439. On July 23, 2003, the Taiwan Intellectual Property Office made an initial determination to grant the cancellation of Taiwan patent NI-139439. On August 22, 2003, OmniVision appealed the decision of the Taiwan Intellectual Property Office to the Taiwan Ministry of Economic Affairs.
On June 30, 2003, Mr. Chia-Chin Ku filed a complaint in Santa Clara County Superior Court against us and our president and chief executive officer, Mr. Shaw Hong. The complaint alleges that, by forming OmniVision in 1995, Mr. Hong breached a fiduciary duty owed to HK Technology, Inc., a privately-held corporation Mr. Hong and others founded in 1988. The complaint further alleges that we “misappropriated and converted” assets and technology belonging to HK Technology, Inc. The complaint seeks damages in an unspecified amount. We believe that we have meritorious defenses to the allegations and claims and intends to defend ourselves vigorously. We understand that HK Technology, Inc. has not engaged in significant substantive operations since the early 1990s. We also understand that HK Technology Inc.’s primary line of business was the design of chipsets for personal computers, and that it did not engage in any business concerning image sensors, which is OmniVision’s primary line of business. We do not believe that OmniVision’s technology or products incorporate or use any proprietary technology of HK Technology, Inc.
On July 14, 2003, Sunex, Inc. filed a complaint against OmniVision in San Diego County Superior Court. Sunex was a supplier of optical lenses and lens holders for one of our cell phone products. Under its complaint, Sunex is seeking to recover approximately $1.8 million plus interest and attorney’s fees. Sunex’s complaint relates to parts delivered by Sunex to OmniVision in the quarter ended April 30, 2003 and our cancellation in that quarter of additional purchase orders we had previously placed with Sunex. We intend to defend ourselves vigorously and have filed a counterclaim against Sunex in which we allege breach of contract and breach of warranties, and seek damages in an amount yet to be determined. We believe that any amount we may ultimately owe Sunex in excess of the amount we had accrued as of April 30, 2003 will not have a material adverse affect on our financial condition or results of operation.
28
Table of Contents
ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS
On July 25, 2003, we issued a warrant to purchase 20,000 shares of our common stock at an exercise price of $32.80 per share to our former chief financial officer. The issuance of the warrant was made in connection with a severance agreement with our former chief financial officer and was exempt from registration under Section 4(2) of the Securities Act.
ITEM 5. OTHER INFORMATION
Non-Audit Services.
In accordance with Section 10A(i)(2) of the Securities Exchange Act of 1934, as added by Section 202 of the Sarbanes-Oxley Act of 2002 (Act), we are required to disclose the non-audit services approved by our Audit Committee to be performed by PricewaterhouseCoopers LLP (PWC), our external auditor. Non-audit services are defined in the Act as services other than those provided in connection with an audit or a review of the financial statements of a company. The Audit Committee has approved the engagement of PWC for non-audit services consisting of tax planning services.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits.
Exhibit | ||||
Number | Description | |||
10.16 | * | Common Stock Purchase Warrant dated July 25, 2003 issued to our former chief financial officer. | ||
31.1 | Certification of Chief Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002. | |||
31.2 | Certification of Chief Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002. | |||
32 | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002. |
* | Previously filed. |
(b) Reports onForm 8-K.
We filed a Current Report on Form 8-K on June 11, 2003 to furnish information that our Board of Directors had issued a press release dated June 11, 2003 announcing our fiscal results for our fourth quarter and fiscal year ended April 30, 2003. Such report was “furnished,” but not “filed.”
We filed a Current Report on Form 8-K on June 11, 2003 relating to our announcement under Rule 135 of the Securities Act of the public sale of our common stock by means of a firm commitment underwritten offering.
We filed a Current Report on Form 8-K on July 11, 2003 relating to the June 30, 2003 filing of a lawsuit against OmniVision.
We filed a Current Report on Form 8-K on June 13, 2003 relating to our announcement of the filing of a registration statement for the public offering of our common stock by means of a firm commitment underwritten offering.
We filed a Current Report on Form 8-K on July 17, 2003 relating to our announcement of the pricing of the public offering of our common stock.
29
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
OmniVision Technologies, Inc. (Registrant) | ||||
Dated: July 14, 2004 | ||||
By: | /s/ Shaw Hong | |||
Shaw Hong Chief Executive Officer, President and Director (Principal Executive Officer) | ||||
Dated: July 14, 2004 | ||||
By: | /s/ John T. Rossi | |||
John T. Rossi Vice President of Finance and Chief Financial Officer (Principal Financial and Accounting Officer) |
30
Table of Contents
EXHIBIT INDEX
Exhibit | ||||
Number | Description | |||
10.16 | * | Common Stock Purchase Warrant dated July 25, 2003 issued to our former chief financial officer. | ||
31.1 | Certification of Chief Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002. | |||
31.2 | Certification of Chief Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002. | |||
32 | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002. |
* | Previously filed. |